$0.3000
At close: Dec 19, 7:55 PM EDT
$0.2620
-0.04-12.67%
After Hours: Dec 19, 7:55 PM EDT
Comments
Loading...
ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW (NASDAQ:CYTO) Stock, Earnings Estimates, EPS, And Revenue
ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Sep 24
EPS
$-2.110
Quarterly Revenue
$34.3K
Annual Revenue
–
Analyze the earnings history of ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW using advanced sorting and filters.
Data brought to you by Benzinga APIs
ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW (CYTO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW (CYTO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW (NASDAQ:CYTO) reporting earnings?
ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on September 24, 2024 for H1.
What were the latest earnings per share (EPS) for ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW (NASDAQ:CYTO)?
ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on September 24, 2024 for H1 and the Actual EPS was $-2.11, which missed the estimate of $0.00.
What were ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW’s (NASDAQ:CYTO) revenues?
ALTAMIRA THERAPUTICS LTD SHS PAR $0.002 NEW ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on September 24, 2024 for H1 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.